Leukocyte Associated Immunoglobulin Like Receptor 2 (LAIR2) Antibody

Este producto es parte de LAIR2 - leukocyte associated immunoglobulin like receptor 2
Product Graph
260€ (50 µl)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
Leukocyte Associated Immunoglobulin Like Receptor 2 (LAIR2) Antibody
category
Primary Antibodies
provider
Abbexa
reference
abx211841
tested applications
ELISA, WB, IHC

Description

LAIR2 Antibody is a Rabbit Polyclonal against LAIR2.

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

Category
Primary Antibodies
Immunogen Target
Leukocyte Associated Immunoglobulin Like Receptor 2 (LAIR2)
Host
Rabbit
Reactivity
Human, Mouse
Recommended Dilution
ELISA: 1/1000 - 1/2000, WB: 1/200 - 1/1000, IHC: 1/25 - 1/100. Optimal dilutions/concentrations should be determined by the end user.
Clonality
Polyclonal
Conjugation
Unconjugated
Isotype
IgG
Purification
Antigen Affinity Chromatography.
Size 1
50 µl
Size 2
100 µl
Form
Liquid
Tested Applications
ELISA, WB, IHC
Buffer
PBS, pH 7.4, containing 0.05% NaN3 and 40% Glycerol.
Availability
Shipped within 5-10 working days.
Storage
Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
Dry Ice
No
UniProt ID
Q6ISS4
Gene ID
3904
Alias
Leukocyte-associated immunoglobulin-like receptor 2,CD306,LAIR-2
Background
Antibody anti-LAIR2
Status
RUO

Descripción

Leukocyte Associated Immunoglobulin-Like Receptor 2 (LAIR2) is a soluble immunoregulatory protein belonging to the immunoglobulin superfamily. LAIR2 functions primarily as a natural inhibitor of immune activation by competing with its membrane-bound counterpart, LAIR1, for binding to collagens present in the extracellular matrix. This competitive binding prevents LAIR1-mediated inhibitory signaling on immune cells such as T cells, natural killer (NK) cells, and dendritic cells, which are crucial for maintaining immune homeostasis and preventing excessive immune activation. LAIR2 is expressed predominantly in immune-related tissues, including the spleen, bone marrow, and lymph nodes, and its soluble nature allows it to circulate freely in the bloodstream, acting as a systemic modulator of collagen-induced immunosuppression. Dysregulated LAIR2 expression has been implicated in various pathological conditions, such as autoimmune diseases, where its elevated levels may counteract excessive immune inhibition, or in cancers, where it could interfere with tumor-induced immunosuppressive microenvironments. Therapeutically, LAIR2 has shown promise as a biomarker for immune dysregulation and as a potential agent in immunotherapy strategies aimed at mitigating immune suppression in cancers or promoting immune tolerance in autoimmune disorders. Its precise role and interactions with other immune checkpoints continue to be a subject of active research, with a focus on leveraging its properties for clinical applications in immune modulation.

Related Products

Pr22949

Recombinant Human LAIR2

Ver Producto
Pr22950

Recombinant Human LAIR2

Ver Producto
abx067774

Human Leukocyte Associated Immunoglobulin Like Receptor 2 (LAIR2) Protein

Recombinant Leukocyte Associated Immunoglobulin Like Receptor 2 (LAIR2) is a recombinant Human protein produced in a Prokaryotic expression system (E. coli).

Ver Producto